Circulating Tumor DNA As a Biomarker for Monitoring Early Treatment Responses of Patients with Advanced Lung Adenocarcinoma Receiving Immune Checkpoint Inhibitors

Paul van der Leest, Birgitta Hiddinga,Anneke Miedema, Maria L. Aguirre Azpurua, Naomi Rifaela, Arja ter Elst,Wim Timens,Harry J. M. Groen, Leon C. van Kempen, T. Jeroen N. Hiltermann, Ed Schuuring

openalex（2021）

Cited 13|Views3

No score

Key words

ctDNA,droplet digital PCR,ICI treatment response monitoring,NSCLC,PD-L1

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined